0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ŭ·Î¸£Çí½Ãµò ±¸°­°£È£¹ýÀÌ ÀΰøÈ£Èí±â °ü·Ã Æó·Å ¹ß»ý·ü°ú »ç¸Á·ü¿¡ ¹ÌÄ¡´Â È¿°ú: ü°èÀû ¹®Çå°íÂû ¹× ¸ÞŸºÐ¼®

Effects of Oral Care Using Chlorhexidine Gluconate on Ventilator-associated Pneumonia and Mortality: A Systematic Review and Meta-analysis

¼ºÀΰ£È£ÇÐȸÁö 2019³â 31±Ç 2È£ p.109 ~ 122
KMID : 0367020190310020109
±è³²¿µ ( Kim Nam-Yong ) - È£³²´ëÇб³ °£È£Çаú

·ù¼¼¾Ó ( Ryu Se-Ang ) - ±¹¸³¸ñÆ÷´ëÇб³ °£È£Çаú
±èÀ±Èñ ( Kim Yun-Hee ) - ±¹¸³¸ñÆ÷´ëÇб³ °£È£Çаú

Abstract

Purpose: This review aimed to determine the effectiveness of oral care using Chlorhexidine Gluconate (CHX) in Ventilator-Associated Pneumonia (VAP) in the intensive care unit.

Methods: An electronic databases search was conducted with Ovid-MEDLINE, EMBASE, CENTRAL, CINAHL and four domestic databases from July 10 to 16, 2018. Two reviewers independently selected the studies; three reviewers assessed their methodological quality and extracted relevant data. We conducted a meta-analysis of the effect of CHX oral care versus placebo using the Review Manager 5.3 software program and summarized the results of intervention from the included studies.

Results: Of the 512 articles identified, 17 randomized controlled trials met the inclusion criteria for review. The incidence of VAP differed significantly between the CHX and placebo groups (Relative Risk [RR]=0.72, 95% Confidence Interval [CI]=0.63~0.84). The pooled effects of oral care using 0.12% CHX were RR=0.65 (95% CI=0.52~0.80) and RR=0.68(95% CI=0.54~0.86) using CHX solution, which were statistically significant. When CHX oral care was performed three times a day, the size of the effect was statistically significant (RR=0.63, 95% CI=0.40~0.99). There was no significant difference in mortality between the CHX oral care and placebo groups (RR=1.08, 95% CI=0.94~1.28).

Conclusion: This review provides evidence that performing oral care using a 0.12% CHX solution three times a day could decrease the incidence of VAP. For improving the quality of nursing practice, the results of this review should be used as the basis for the oral care evidence-based practice guidelines for critical patients.
KeyWords
ÁßȯÀÚ, Æó·Å, ±¸°­°£È£, Ŭ·Î¸£Çí½Ãµò, ¸ÞŸºÐ¼®
Critical illness, Pneumonia, Oral hygiene, Chlorhexidine, Meta-analysis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed